149 related articles for article (PubMed ID: 19934340)
1. A proposed unified mechanism for the reduction of human breast cancer risk by the hormones of pregnancy.
Jacobson HI; Lemanski N; Agarwal A; Narendran A; Turner KE; Bennett JA; Andersen TT
Cancer Prev Res (Phila); 2010 Feb; 3(2):212-20. PubMed ID: 19934340
[TBL] [Abstract][Full Text] [Related]
2. Hormones of pregnancy, alpha-feto protein, and reduction of breast cancer risk.
Jacobson HI; Lemanski N; Narendran A; Agarwal A; Bennett JA; Andersen TT
Adv Exp Med Biol; 2008; 617():477-84. PubMed ID: 18497072
[TBL] [Abstract][Full Text] [Related]
3. Hormonal approach to breast cancer prevention.
Russo IH; Russo J
J Cell Biochem Suppl; 2000; 34():1-6. PubMed ID: 10762007
[TBL] [Abstract][Full Text] [Related]
4. Prevention of N-methyl-N-nitrosourea-induced breast cancer by alpha-fetoprotein (AFP)-derived peptide, a peptide derived from the active site of AFP.
Parikh RR; Gildener-Leapman N; Narendran A; Lin HY; Lemanski N; Bennett JA; Jacobson HI; Andersen TT
Clin Cancer Res; 2005 Dec; 11(23):8512-20. PubMed ID: 16322315
[TBL] [Abstract][Full Text] [Related]
5. Alpha-fetoprotein derived from a human hepatoma prevents growth of estrogen-dependent human breast cancer xenografts.
Bennett JA; Zhu S; Pagano-Mirarchi A; Kellom TA; Jacobson HI
Clin Cancer Res; 1998 Nov; 4(11):2877-84. PubMed ID: 9829755
[TBL] [Abstract][Full Text] [Related]
6. Toward a physiological approach to breast cancer prevention.
Russo J; Russo IH
Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):353-64. PubMed ID: 8061586
[TBL] [Abstract][Full Text] [Related]
7. Hormone levels and mammary epithelial cell proliferation in rats treated with a regimen of estradiol and progesterone that mimics the preventive effect of pregnancy against mammary cancer.
Swanson SM; Whitaker LM; Stockard CR; Myers RB; Oelschlager D; Grizzle WE; Juliana MM; Grubbs CJ
Anticancer Res; 1997; 17(6D):4639-45. PubMed ID: 9494582
[TBL] [Abstract][Full Text] [Related]
8. Hormonal and environmental factors affecting cell proliferation and neoplasia in the mammary gland.
Snedeker SM; Diaugustine RP
Prog Clin Biol Res; 1996; 394():211-53. PubMed ID: 8778798
[TBL] [Abstract][Full Text] [Related]
9. Estradiol and progesterone can prevent rat mammary cancer when administered concomitantly with carcinogen but do not modify surviving tumor histology, estrogen receptor alpha status or Ha-ras mutation frequency.
Swanson SM; Christov K
Anticancer Res; 2003; 23(4):3207-13. PubMed ID: 12931682
[TBL] [Abstract][Full Text] [Related]
10. Growth inhibition of estrogen-sensitive rat mammary tumors. Effect of an alpha-fetoprotein-secreting hepatoma.
Sonnenschein C; Ucci AA; Soto AM
J Natl Cancer Inst; 1980 May; 64(5):1147-52. PubMed ID: 6154169
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of estrogen-dependent breast cancer growth by a reaction product of alpha-fetoprotein and estradiol.
Jacobson HI; Bennett JA; Mizejewski GJ
Cancer Res; 1990 Jan; 50(2):415-20. PubMed ID: 1688512
[TBL] [Abstract][Full Text] [Related]
12. Effects of parity on pregnancy hormonal profiles across ethnic groups with a diverse incidence of breast cancer.
Arslan AA; Zeleniuch-Jacquotte A; Lukanova A; Afanasyeva Y; Katz J; Levitz M; Del Priore G; Toniolo P
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2123-30. PubMed ID: 17119037
[TBL] [Abstract][Full Text] [Related]
13. Mean arterial pressure, pregnancy-induced hypertension, and preeclampsia: evaluation as independent risk factors and as surrogates for high maternal serum alpha-fetoprotein in estimating breast cancer risk.
Richardson BE; Peck JD; Wormuth JK
Cancer Epidemiol Biomarkers Prev; 2000 Dec; 9(12):1349-55. PubMed ID: 11142421
[TBL] [Abstract][Full Text] [Related]
14. Estrogen and progesterone treatment mimicking pregnancy for protection from breast cancer.
Tsubura A; Uehara N; Matsuoka Y; Yoshizawa K; Yuri T
In Vivo; 2008; 22(2):191-201. PubMed ID: 18468403
[TBL] [Abstract][Full Text] [Related]
15. Maternal serum testing for alpha-fetoprotein and human chorionic gonadotropin in high-risk pregnancies.
Jauniaux E; Gulbis B; Tunkel S; Ramsay B; Campbell S; Meuris S
Prenat Diagn; 1996 Dec; 16(12):1129-35. PubMed ID: 8994249
[TBL] [Abstract][Full Text] [Related]
16. Hormone-induced protection against mammary tumorigenesis is conserved in multiple rat strains and identifies a core gene expression signature induced by pregnancy.
Blakely CM; Stoddard AJ; Belka GK; Dugan KD; Notarfrancesco KL; Moody SE; D'Cruz CM; Chodosh LA
Cancer Res; 2006 Jun; 66(12):6421-31. PubMed ID: 16778221
[TBL] [Abstract][Full Text] [Related]
17. Potential benefits of estrogens and progestogens on breast cancer.
Schneider HP; Jackisch C
Int J Fertil Womens Med; 1998; 43(6):278-85. PubMed ID: 9920536
[TBL] [Abstract][Full Text] [Related]
18. Treatment with human chorionic gonadotropin and risk of breast cancer.
Bernstein L; Hanisch R; Sullivan-Halley J; Ross RK
Cancer Epidemiol Biomarkers Prev; 1995; 4(5):437-40. PubMed ID: 7549796
[TBL] [Abstract][Full Text] [Related]
19. Human chorionic gonadotropin and alpha-fetoprotein concentrations in pregnancy and maternal risk of breast cancer: a nested case-control study.
Lukanova A; Andersson R; Wulff M; Zeleniuch-Jacquotte A; Grankvist K; Dossus L; Afanasyeva Y; Johansson R; Arslan AA; Lenner P; Wadell G; Hallmans G; Toniolo P; Lundin E
Am J Epidemiol; 2008 Dec; 168(11):1284-91. PubMed ID: 18936438
[TBL] [Abstract][Full Text] [Related]
20. Effects of different durations of estrogen and progesterone treatment on development of N-methyl-N-nitrosourea-induced mammary carcinomas in female Lewis rats.
Yuri T; Tsukamoto R; Uehara N; Matsuoka Y; Tsubura A
In Vivo; 2006; 20(6B):829-36. PubMed ID: 17203775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
